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Adaptation of an enzyme to regulatory function: structure of
Bacillus subtilis PyrR, a pyr RNA-binding attenuation protein 
and uracil phosphoribosyltransferase
Diana R Tomchick1, Robert J Turner2†, Robert L Switzer2 and Janet L Smith1*
Background: The expression of pyrimidine nucleotide biosynthetic (pyr) genes
in Bacillus subtilis is regulated by transcriptional attenuation. The PyrR
attenuation protein binds to specific sites in pyr mRNA, allowing the formation
of downstream terminator structures. UMP and 5-phosphoribosyl-1-
pyrophosphate (PRPP), a nucleotide metabolite, are co-regulators with PyrR.
The smallest RNA shown to bind tightly to PyrR is a 28–30 nucleotide stem-
loop that contains a purine-rich bulge and a putative GNRA tetraloop. PyrR is
also a uracil phosphoribosyltransferase (UPRTase), although the relationship
between enzymatic activity and RNA recognition is unclear, and the UPRTase
activity of PyrR is not physiologically significant in B. subtilis. Elucidating the
role of PyrR structural motifs in UMP-dependent RNA binding is an important
step towards understanding the mechanism of pyr transcriptional attenuation.
Results:  The 1.6 Å crystal structure of B. subtilis PyrR has been determined by
multiwavelength anomalous diffraction, using a Sm co-crystal. As expected, the
structure of PyrR is homologous to those proteins of the large type I PRTase
structural family; it is most similar to hypoxanthine-guanine-xanthine PRTase
(HGXPRTase). The PyrR dimer differs from other PRTase dimers, suggesting it
may have evolved specifically for RNA binding. A large, basic, surface at the
dimer interface is an obvious RNA-binding site and uracil specificity is probably
provided by hydrogen bonds from mainchain and sidechain atoms in the hood
subdomain. These models of RNA and UMP binding are consistent with
biological data.
Conclusions: The B. subtilis protein PyrR has adapted the substrate- and
product-binding capacities of a PRTase, probably an HGXPRTase, producing a
new regulatory function in which the substrate and product are co-regulators of
transcription termination. The structure is consistent with the idea that PyrR
regulatory function is independent of catalytic activity, which is likely to be
extremely low under physiological conditions.
Introduction
The Bacillus subtilis protein PyrR regulates the expression
of the pyrimidine nucleotide (pyr) biosynthetic pathway by
modulating the attenuation of transcription at three points
in the pyr operon, in response to exogenous pyrimidines
[1,2]. PyrR exerts its regulatory function by binding, in the
presence of the co-regulator UMP, to the pyr mRNA tran-
scripts of the attenuator regions of the operon and disrupt-
ing an antiterminator stem-loop secondary structure. This
permits the downstream stem of the antiterminator to par-
ticipate in formation of an alternative stem-loop structure,
which is a factor-independent transcription terminator
(Figure 1a). In this way, UMP-dependent binding of PyrR
converts the transcription system from a readthrough
mode, which permits expression of the downstream pyrim-
idine biosynthetic genes, to a termination mode, which
reduces expression of these genes.
The model for transcriptional attenuation of the B. subtilis
pyr operon, originally based on molecular genetic experi-
ments [1], was confirmed by reconstruction of transcrip-
tional attenuation in vitro [3,4]. Together UMP and PyrR
strongly promoted transcriptional termination in a simple
in vitro system consisting of purified B. subtilis RNA poly-
merase, pyr DNA templates, rNTP substrates and purified
PyrR. Only UMP and UTP promoted termination,
whereas 5-phosphoribosyl-1-pyrophosphate (PRPP), a
central nucleotide metabolite, antagonized the action of
UMP on termination. The segments of pyr mRNA to
which PyrR binds were identified from conservation of
their sequences in the three pyr attenuation regions [1].
Gel mobility shift analysis shows that purified PyrR binds
with high affinity and specificity to the expected RNA
segments [5]. PyrR affinity for RNA is increased in the
presence of UMP. A minimal sequence of 28 nucleotides
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within the RNA segment is required for PyrR binding.
The target RNA folds into a stem-loop secondary struc-
ture called the anti-antiterminator or the binding loop ([4];
ER Bonner, J D’Elia and RLS, unpublished results)
(Figure 1b).
PyrR belongs to a growing class of proteins that regulate
transcriptional attenuation by binding to mRNA, thereby
altering the frequency of transcription termination [6–13].
Such proteins provide a very general mechanism for the
regulation of gene expression, a mechanism that is in prin-
ciple as general as the regulation of transcriptional initia-
tion by the binding of repressors or activator proteins to
operator sites in DNA. High-resolution structures of the trp
RNA-binding attenuation protein (TRAP) from B. subtilis
[14] and of the RNA-binding domain of B. subtilis SacY
[12,13] have been described, and although the specific
RNA sequences to which they bind are known, the details
of protein–RNA recognition are not yet fully defined.
Analysis of the deduced amino acid sequences of TRAP
and SacY does not reveal any relationship of these proteins
to each other, to PyrR or to the recognized sequence motifs
found in other RNA-binding proteins [15,16].
PyrR has another remarkable property: it is an enzyme.
PyrR is a uracil phosphoribosyltransferase (UPRTase),
even though its primary sequence bears little resemblance
to those of other bacterial UPRTases, except for a short
sequence that is characteristic of nearly all PRPP-binding
proteins [1]. Other than the provision of specific sites for
the binding of the regulatory metabolites UMP and PRPP,
it is not clear why PyrR should possess enzymatic activity,
nor is it certain that this activity is required for the normal
regulatory functions of PyrR. The UPRTase activity of
PyrR is not quantitatively important in B. subtilis cells
[1,17]. These bacteria also produce another UPRTase,
encoded by the upp gene, which lies outside of the pyr
operon. The upp gene product has much greater sequence
similarity to other bacterial UPRTases and contributes
most of the UPRTase activity of the cell under physiologi-
cal conditions. UPRTase activity of PyrR at physiological
pH is extremely low [5]. Phosphoribosyltransferases
(PRTases) are enzymes involved in nucleotide synthesis
and salvage; they catalyze the displacement of PRPP
pyrophosphate by nitrogenous compounds, mostly from
purine and pyrimidine bases. Crystal structures of several
PRTases have been reported [18–25]. Very recently, the
structure of the upp-encoded UPRTase from Bacillus
caldolyticus was determined (A Kadziola and S Larsen,
personal communication). An additional objective of the
present work is to understand the structural relationships
between these enzymes and PyrR, which differs so
markedly from them in biochemical function.
PyrR is not unique to B. subtilis (Figure 2). Homologs that
probably function in the regulation of pyr genes have been
found in B. caldolyticus [26,27], Enterococcus faecalis ([28];
S-Y Ghim, JH Kim, ER Bonner, GK Grabner and RLS,
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Figure 1
Transcriptional attenuation of pyr gene
expression in B. subtilis. (a) Schematic
representation of the transcriptional attenuation
mechanism of PyrR. Numbered segments
correspond to base paired stems of the
proposed RNA secondary structures shown in
the lower half of the figure. In the absence of
PyrR binding (left), pairing of segments 1 and 2
leads to formation of the antiterminator stem-
loop, which prevents segment 3 from base-
pairing with segment 4. Transcription
termination is prevented and downstream
genes are transcribed. UMP-stimulated PyrR
binding to segment 1, which stabilizes the
alternative anti-antiterminator stem-loop (right),
disrupts the antiterminator and frees segment 3
for base pairing with segment 4 to form a
factor-independent terminator structure.
Increased transcription termination reduces
expression of the downstream genes. (b)
Proposed secondary structure of the anti-
antiterminator stem-loop from the pyrR–pyrP
attenuation region. The sequence shown binds
tightly and specifically to PyrR [5]. The
structure shown is that predicted by the
PCFOLD program of Zuker and Stiegler [69],
except that the pentaloop at the top has been
folded to form a GNRA tetraloop [53].
UMP
1 2
3 4
pyr genes
mRNA
low [UMP]
[PRPP] high
[UMP]
[PRPP]
UUUUU
1 2
3
4
4
3
2
1 pyr genes
PyrR
PRPP
PyrR
Antitermination Termination
G
C
C
A
A
C
G
A
U
G
G
A
A
U
U
U
U
U
C
C
A
C
A
G
A
G
G
U
U
G
C
A
A
A
G
A
G
G
U
G
Structure
(a) (b)
unpublished results), and Lactobacillus plantarum [29]. The
identification of a typical attenuator sequence at the 5¢
end of the Lactococcus lactis pyrKDbF operon suggests that
a PyrR protein is also produced by this organism [30]. A
pyrR gene was also identified in the Thermus strain ZO5
and was proposed to regulate pyr gene expression by RNA
binding [31], but by a mechanism that differs substantially
in detail from that established for B. subtilis. Genes with
open reading frames having significant sequence similarity
to B. subtilis pyrR have also been identified in the genomes
of Haemophilus influenzae [32], Mycobacterium tuberculosis
[33] and a Synechocystis species [34], but the functions of
any protein products of these genes are unknown.
Knowledge of the three-dimensional structure of PyrR is a
necessary step in determining how PyrR recognizes specific
pyr mRNA sequences in a UMP-dependent manner. A
simple procedure for the isolation of PyrR mutants with
defects in the regulation of expression of the pyr operon has
been developed [35]; analysis of these mutants would be
greatly aided by the availability of a high-resolution struc-
ture of this protein. We report here the crystal structures of
two forms of PyrR not bound by ligand, a dimeric form to
1.6 Å resolution and a hexameric form to 2.3 Å. The mol-
ecular architecture of PyrR is typical of a type I PRTase,
but the interaction between monomers to form dimers is
quite different from the other members of the PRTase
family. The electrostatic surface potential of the dimeric
form of PyrR suggests an obvious RNA-binding face.
Results
The structures of two ligand-free forms of PyrR, a dimeric
form to 1.6 Å resolution and a hexameric form to 2.3 Å res-
olution, have been determined. Crystals of the hexameric
form were obtained initially; heavy-atom screening to solve
the phase problem led to the crystallization of the dimeric
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Structure
Sequence alignment of the PyrR homologs. Residues identical in all
homologs are highlighted in red and similar residues are highlighted in
yellow and boxed. The secondary structure and sequence numbering
for the B. subtilis protein are indicated; cylinders represent a helices
and arrows represent b strands. The following loops are labeled: the
trimer loop, which contributes to the threefold interface in the hexamer
and is disordered in the dimeric structure; the flexible loop, which is
near the PRTase active site and is disordered in both structures; the
dimer loop, which forms the primary dimer contact; and the PRPP
loop, which contains the PRPP sequence motif. Open triangles
indicate the complete PRPP sequence motif, filled magenta triangles
indicate the spontaneous mutations of the B. subtilis protein isolated
by Ghim and Switzer [35] and the filled blue circles indicate site-
directed mutations of B. subtilis PyrR that lead to defects in pyrimidine
regulation (H Savacool and RLS, unpublished results). Amino acid
substitutions of the mutations are given beneath the blue circles and
magenta arrows. The figure was prepared with ALSCRIPT [70].
form, which were Sm3+ co-crystals. The structure of the
dimeric form was solved by multiwavelength anomalous
diffraction (MAD), and the resulting PyrR structural model
was used to solve the structure of the hexameric form by
molecular replacement. Sm3+ prevents threefold aggrega-
tion of dimers by binding to PyrR residues that contribute
to the threefold subunit contact of the hexamer.
Subunit structure
The PyrR monomer (Figure 3a) displays an overall archi-
tecture similar to other type I PRTases [18–23,25,36]. The
type I PRTase monomers are composed of a core domain
that contains a parallel b sheet (b 3, b 2, b 5, b 6 and b 7),
flanked by a helices (a 1, a 2 and a 3), and a second domain
or subdomain. The core domain (residues 10–157 in PyrR)
includes the active site, principal elements of which are
the ‘PRPP loop’, the ‘PPi loop’ and the ‘PRTase flexible
loop’. The PRPP loop, which connects the central b strand
(b 5 in PyrR) and the following a helix (a 3), binds the
ribose-5-phosphate moiety of PRPP. It is also the central
segment of a sequence motif (101VILVDDVLYTGRT113),
conserved in type I PRTases. The PPi loop, connecting b 2
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Figure 3
Tertiary and quaternary structure of PyrR.
(a) Stereo Ca trace of the PyrR monomer
from the hexamer structure. The chain trace is
numbered at every twentieth residue, and a
dashed line representing the disordered
residues of the PRTase flexible loop is drawn
for residues 73–84. The PRPP loop, residues
101–113, is shown in green. (b) Stereo view
of the PyrR dimer from the dimer crystal
structure. One monomer is depicted with
green helices and red b strands, and the other
with blue helices and yellow b strands. The
disordered residues of the trimer loop
(residues 30–33) and the PRTase flexible
loop (74–81) are indicated by the dashed
black lines. Black spheres represent the
positions of the Sm3+ ions used in the MAD
structure determination. (c) Orthogonal views
of the PyrR hexamer. The left-hand view is
along the threefold axis, and the right-hand
view is along a twofold axis. The approximate
outer dimensions of the hexamer are 59 Å by
73 Å. The six monomers are colored
differently. The figure was prepared with the
program MOLSCRIPT [71].
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and a 2, binds the PPi moiety of PRPP [37,38] and is adja-
cent to the PRPP loop. The PRTase flexible loop,
between b 3 and b 4, becomes ordered and closes the active
site during catalysis; it includes residues that bind the
pyrophosphate group of PRPP [38]. Residues 74–81 of the
PRTase flexible loop in PyrR are disordered, as in most
other PRTase structures. The second domain or sub-
domain (residues 3–9 and 158–180 in PyrR) specifically
binds the nucleophile that will displace the pyrophos-
phate group from PRPP and is known as the ‘hood’ in
those PRTases in which it is a small subdomain [18]. A
second PRTase structural family was identified recently
and is unrelated to PyrR [24].
The PRTase structural elements of substrate and product
binding — the PRPP loop, the PPi loop, the flexible loop
and the hood — are interpreted in terms of PyrR function
because the UPRTase substrate and product — PRPP
and UMP — are PyrR co-regulators. In both oligomeric
forms of PyrR, a sulfate anion from the crystallization
medium is bound in the PRPP loop, to the binding site
for the 5 ¢ -phosphate of PRTase substrates, products or
inhibitors. The sidechain of Lys40 in the PPi loop is
extended across the active-site cleft and forms a salt
bridge to the sulfate ion. Similar anion binding occurs in
Salmonella typhimurium orotate PRTase (OPRTase), in
which the corresponding lysine residue, Lys73, forms a
salt bridge with the 5 ¢ -phosphate group in the OMP
complex [18], and with the pyrophosphate group in the
orotate–PRPP complex [37]. In several other PRTase
structures, the PPi loop includes a cis peptide, specifically
cis-Thr47 in the GMP-bound T. foetus hypoxanthine-
guanine-xanthine PRTase (HGXPRTase) [21], cis-Tyr72
in E. coli OPRTase [23], cis-Asp282 in B. subtilis glutamine
PRPP amidotransferase (GPATase) [39], cis-Glu303 in
E. coli GPATase [36] and cis-Arg37 in E. coli XPRTase
[25]. In our structure of PyrR, Lys40 is the trans confor-
mation, but adopts an unfavorable backbone conformation
( f = +73°, y = +155°). In the structure of HGXPRTase
from Toxoplasma gondii in complex with the product
XMP, the equivalent residue (Lys79) of the PPi loop is
3–4 Å closer to the active site than in the free enzyme; a
cis-peptide has not been reported for this residue [22].
Dimeric PyrR
The PyrR dimer has a flattened disc shape with maximal
dimensions of 73 Å by 49 Å by 34 Å (Figure 3b). The
PRTase active sites are separated by approximately 30 Å.
Dimerization occurs through helix a 3, strand b 6 and the
long ‘dimer loop’ between strands b 6 and b 7; the molecu-
lar dyad is also a crystallographic twofold axis. Five sym-
metric pairs of hydrogen bonds surround a hydrophobic
core in this interface, which buries a total of 820 A2 of
surface area per monomer, approximately 11% of the
monomer surface area. The buried surface area and
number of hydrogen bonds in the dimer interface are
similar to a typical protease–inhibitor or antibody–antigen
complex [40–43]. Residues 30–33 are disordered in the
crystals of dimeric PyrR.
The PyrR subunit dimerizes very differently to other type
I PRTases (Figure 4). As a result, the two active sites are
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Figure 4
Unique dimer interface of PyrR. The stereo
view shows Ca traces for the dimers of
B. subtilis PyrR (thick lines) and T. foetus
HGXPRTase (thin lines). A monomer of
HGXPRTase is superimposed on a monomer
of PyrR, illustrating the very similar structure of
the two proteins. The positions of the second
monomers demonstrate the radically different
dimerization mode of PyrR. All other type I
PRTases of reported structure dimerize in a
similar manner to HGXPRTase. The rmsd
values for superposition of other PRTase
monomers on PyrR are: 1.67 Å for 124
common Ca atoms with HGXPRTase ([21];
PDB code 1HGX); 1.48 Å for 103 common
Ca atoms with HGPRTase ([20]; 1HMP);
1.44 Å for 83 common Ca atoms with
XPRTase ([25]; 1NUL); 1.41 Å for 68 common
Ca atoms with S. typhimurium OPRTase
([18]; 1STO); 1.33 Å for 70 common Ca
atoms of E. coli OPRTase ([23]; 1ORO);
1.58 Å for 65 common Ca atoms with E. coli
GPATase ([51]; 1ECF); and 1.46 Å for 63
common Ca atoms with B. subtilis GPATase
([39]; 1AO0). The figure was prepared with
the program MOLSCRIPT [71].
Structure
on opposite ends of the PyrR dimer, in contrast to other
PRTases in which the two active sites are near the dimer
interface, where the flexible loop may contribute to both
active sites [23,37,38]. Each PyrR monomer must therefore
comprise all of the residues necessary for catalysis, includ-
ing basic residues that can interact with the pyrophosphate
group of PRPP. The conserved residues (Figure 2) in PyrR
that are near the active site and may interact with the 1-
pyrophosphate group of PRPP are Lys40 and Arg42 in the
PPi loop and Arg73 in the flexible loop. In agreement with
the structural data, there is no kinetic evidence for site–site
interactions in the UPRTase reaction catalyzed by PyrR
[5]. This is in contrast to the UPRTase from E. coli, which
is positively regulated by the allosteric effector GTP and
displays increased activity upon GTP- and PRPP-induced
higher oligomerization [44].
Lanthanide ions disrupt subunit contacts along the three-
fold axis of the PyrR hexamer and were essential to crys-
tallization of the dimeric form. Calcium ions do not have
the same effect despite their similar radius, ligand prefer-
ence and protein-binding sites [45], even at 50-fold greater
concentration (100 mM versus 2 mM). The coordination
geometry of Sm3+ does not explain the ion selectivity,
which may be due to the greater electropositivity of lan-
thanide ions in the 3+ state compared with Ca2+. Sm3+
crosslinks PyrR dimers in the crystal because it is located
on a crystallographic twofold axis and is octahedrally coor-
dinated to the sidechains of Glu10, Asp167 and Asp173
and their twofold symmetry mates. Binding of the more
bioavailable Ca2+ in the same manner would have rather
deleterious effects on PyrR function because of the possi-
bility of forming extended polymers of dimers. A second
fully hydrated Sm3+ binds near the PRTase flexible loop,
where it may influence loop conformation.
Hexameric PyrR
The PyrR hexamer is a trimer of the dimer structure
described above, having D3 molecular symmetry
(Figure 3c). Molecular and crystallographic threefold axes
are coincident; the molecular twofold axis of the hexamer
is noncrystallographic. The hexamer shape resembles a
flattened hollow cylinder, approximately 59 Å high along
the threefold cylinder axis and 73 Å wide. The diameter of
the inner space is approximately 30 Å, at its widest point
in the center of the hexamer, and 8 Å at its narrowest near
the top and bottom. The 8 Å opening is too small to
accommodate any form of RNA. Threefold contacts are
formed between the hood of one monomer and the
PRTase core of another. Each subunit interface buries
approximately 380 Å2 of surface area per monomer, less
than half the surface area buried in the dimer interface,
and includes one salt bridge, several van der Waals con-
tacts and no hydrogen bonds. An important contributor to
the threefold contact is the ‘trimer loop’ (residues 30–33),
which is disordered in the crystal structure of dimeric
PyrR. The trimer loop contacts hood residues 5–8 of a
threefold related subunit, and the sidechain of Met31 is
buried within its own subunit.
The PyrR dimer interface is flexible, as evident in com-
parison of the dimer and hexamer structures. The root
mean square deviation (rmsd) for superposition of the 320
common Ca atoms in the dimers for the two oligomeriza-
tion states is 0.98 Å. This reflects a small (3°) rotation of
monomers at the dimer interface. Individual monomers
superimpose with an rmsd of 0.53 Å.
Discussion
PyrR aggregation state
The aggregation state of PyrR is variable. The apparent
molecular weight for the major species eluted in gel filtra-
tion experiments is directly proportional to protein concen-
tration [5]. On the basis of the crystal structures, rapid
equilibrium between dimeric and hexameric species is
inferred. The small buried surface area and lack of hydro-
gen bonds in the threefold interface of the hexamer imply
that it is not a biologically relevant subunit interaction [46].
The hexameric form of PyrR therefore may be non-physio-
logical and due only to the relatively high in vitro concen-
trations used during both gel filtration and crystallographic
studies. The aggregation state of PyrR when complexed
with RNA has not been determined, but we propose that
PyrR is a dimer at intracellular concentrations.
Relationship to other phosphoribosyltransferases
Type I PRTases from different biological sources that
catalyze the same reaction (orthologs) typically show sig-
nificant sequence identity; however, the family is charac-
terized by low sequence identity (< 20%) among PRTases
that catalyze different reactions (paralogs). Indeed, family
members are most easily identified at the sequence level
by the characteristic motif of the PRPP loop. The six dif-
ferent type I PRTases of known structure have a common
fold and active-site structure, as expected, despite their
low overall sequence identity. PyrR occupies a distinct
branch on the family tree of type I PRTases.
PyrR and the upp-encoded bacterial UPRTases appear to
be distant PRTase relatives, even though they catalyze
the same chemical reaction. The sequence identity
between B. subtilis PyrR and upp-encoded UPRTase is
only 15%, outside of the PRPP sequence motif region.
The UPRTases are typically 30 residues longer than PyrR
and its close homologs, due mostly to insertions in the
hood subdomain. There are two differences in the PRPP
sequence motif between these proteins. Firstly, the
second of the two conserved aspartate residues in PyrR
(Asp106) is a proline in the UPRTases; the carboxylate
group of this acidic residue interacts with O3 ¢ of ribose
hydroxyl groups in nucleotide–type I PRTases complexes
[22,38,39]. Secondly, a conserved aromatic residue in
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PurR (Tyr109), which may stack on the uracil base of
UMP, is an alanine in the UPRTases.
The structure of the PyrR subunit is more similar to the
structures of Tritrichomonas foetus HGXPRTase [21] and
human HGPRTase [20] than to the other type I PRTase
structures (Figure 4). A core of 124 Ca atoms are struc-
turally equivalent in PyrR and T. foetus HGXPRTase; the
largest differences occur in the PRTase flexible loop and
the hood. In contrast, structures of UPRTase, XPRTase,
OPRTase and GPATase have only 60–80 residues struc-
turally equivalent to those of PyrR. The significant differ-
ence in number of equivalent residues is because some
structural elements shared by PyrR and HG(X)PRTase
differ from those of other PRTases; these include a simi-
larly folded hood, a loop rather than a helix in the last
crossover connection of the central parallel b sheet and a
shelf-like extension on the central b sheet. PyrR may there-
fore have originated from an HG(X)PRTase and has been
optimized to bind UMP and RNA. The existence of a rela-
tionship between PyrR and HG(X)PRTase is also indicated
by the greater, albeit low, similarity between the amino acid
sequences of PyrR and HG(X)PRTases than between PyrR
and other PRTases (RJT, unpublished results).
Regulatory versus catalytic function of PyrR
The primary function of PyrR is to regulate transcription
of genes for pyrimidine biosynthesis. It has not been
established whether PyrR catalytic activity is essential to
this regulatory function. PyrR displays typical PRTase
activity under nonphysiological conditions (pH 8.5);
however, the Km for uracil rises sharply as the pH is
decreased to physiological values and is probably much
higher (> 1 mM) than the intracellular uracil concentration
[5]. On the basis of these data, we propose that the cat-
alytic activity of PyrR is not an essential feature of its reg-
ulatory function. UPRTase activity of PyrR may be
impaired at neutral pH by lack of a suitable base for
deprotonation of uracil (pK = 9.5). The identity of the cat-
alytic base has not been established for any PRTase, so
there is little basis for comparison of active-site structures.
Substrate-assisted catalysis with the PPi leaving group as
the catalytic base has been proposed in a structure-based
mechanism for GPATase [38]. Catalysis by such a mecha-
nism could be impaired in PyrR by binding PRPP in a
non-optimal conformation.
Nonenzymatic regulatory function of a type I PRTase
homolog has also been characterized in another system.
Expression of genes for de novo purine biosynthesis in B.
subtilis is controlled by a protein that contains the PRTase
sequence motif [47]. This dimeric purine repressor (PurR)
regulates transcription initiation of the pur operon in vivo
in response to excess adenine, but is not related to E. coli
PurR or other members of the LacI family. Binding of B.
subtilis PurR to control-region DNA in vitro is inhibited by
PRPP, yet is unaffected by nucleotides or purines [48].
The 25% sequence identity between PurR and B. subtilis
XPRTase indicates that PurR is a member of the type I
PRTase structural family. No PRTase enzymatic activity
was detected for this repressor protein [48].
PyrR homologs
In contrast to the low sequence identity it has with other
type I PRTases, PyrR has significant sequence identity
(45–73%) with a group of other bacterial proteins. The
structure of PyrR should be an excellent three-dimen-
sional model for these homologs. In the context of the
type I PRTase family, the high level of sequence identity
among homologs is itself evidence that the proteins have a
common function. PyrR homologs have been implicated
in the regulation of transcription of genes involved in
pyrimidine biosynthesis in B. subtilis, B. caldolyticus, E.
faecalis and L. plantarum. Other potential homologs from
Thermus ZO5, Mycobacterium tuberculosis, Haemophilus
influenzae and a Synechocystis species have been identified
at gene level. Attenuation sequences and candidate PyrR
regulatory sites are present in all these organisms, except
H. influenzae and the Synechocystis species. Three highly
conserved regions are identified in the sequence align-
ment of the eight PyrR homologs (Figure 2). These are
the PRTase flexible loop (70–75), the PRPP loop
(101–113) and dimer loop (138–146). Conservation of the
dimer loop implies that all of the PyrR homologs dimerize
in the same way as the B. subtilis protein. The dimer loop
also contributes to a large basic surface that may be impor-
tant for RNA interactions. In the trimer loop of PyrR, the
sequence 28NKGX31 (where X is a small preferably
hydrophobic residue) forms a type III¢ reverse turn that
makes hydrophobic contacts in the PyrR hexamer. The
sidechains of Lys29 and Arg27 make hydrophobic con-
tacts with Ile177 and Pro155, respectively, at the threefold
interface. Five of the eight PyrR homologs contain the
NKGX sequence motif; at elevated concentrations, these
proteins may form hexamers like the PyrR hexamer.
Relationship of PyrR to other RNA-binding attenuation
regulatory proteins
Transcriptional attenuation is a common mechanism of
gene regulation in eubacteria, and several proteins that
regulate attenuation have been identified. None of these
other transcriptional attenuation proteins appear to be
related to PyrR or its homologs, and none of them include
the PRTase sequence motif. Three-dimensional struc-
tures have been determined for two of these attenuator
proteins [12–14], but no structures of these proteins in
complex with RNA have been reported.
The B. subtilis tryptophan RNA-binding attenuation
protein (TRAP; [9]) controls transcription of the trp operon
in response to changes in the intracellular levels of trypto-
phan. Like UMP-bound PyrR, tryptophan-bound TRAP
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induces formation of an mRNA stem-loop terminator in the
control region of the operon. Similarly, in the absence of
TRAP, formation of an alternative antiterminator is favored.
Neither the undecamer TRAP structure [14] nor the 11-
fold trinucleotide repeat to which it binds are similar to the
PyrR transcription attenuation system, however.
Another major family of transcriptional attenuation pro-
teins controls transcription of genes involved in the uti-
lization of aromatic b -glucosides and oligosaccharides.
The non-phosphorylated dimeric forms of E. coli BglG
[49] and B. subtilis SacY [7,12,13] are postulated to recog-
nize a 29-nucleotide mRNA antiterminator stem-loop that
overlaps with the downstream terminator stem-loop [6,50].
Despite their common dimeric aggregation and the similar
sizes of their RNA stem-loop recognition sites, PyrR and
SacY/BglG are unrelated proteins [12,13]. Likewise,
details of the RNA recognition sequences are dissimilar
(E Bonner, J D’Elia and RLS, unpublished results; [50]).
Model of RNA binding
UMP and PRPP are the physiological effectors of tran-
scription attenuation by PyrR. Our working hypothesis is
that UMP and PRPP bind PyrR in the same way for tran-
scription attenuation as for catalytic turnover, in a manner
similar to the binding of nucleotide products and PRPP
substrate to other type I PRTases. PyrR binds RNA
specifically in absence of effectors, but binding is
enhanced by UMP [5]. Likewise, PRTase structures are
very similar with and without their nucleotide products
[21,22,39,51]. Only subtle structural differences are there-
fore anticipated in PyrR with and without UMP, and the
crystal structures of apo PyrR should be a reasonable start-
ing point for modeling both UMP and RNA complexes.
A stem-loop pyr mRNA model was constructed to reflect
the specific sequence and predicted secondary structure
elements of the RNA target sequence (Figure 1b). Two
features of the RNA stem-loop sequence that are con-
served among pyr attenuation regions and are sensitive to
mutagenesis [52] are the loop, which is proposed to form a
GNRA tetraloop, and a purine-rich four-nucleotide bulge
in the stem. The GNRA tetraloop is a common, stable,
RNA structural motif in which the N (any) and R (purine)
bases are stacked over the A base of a G–A base pair
[53,54]. The choice of a GNRA tetraloop, as opposed to
other possible loops is conjectural at this time. RNA stem-
loops built with other types of loops could also be
modeled onto the surface of PyrR. To build the 28-
nucleotide pyr mRNA stem-loop, the GNRA tetraloop of a
DNA–RNA hammerhead ribozyme [54] was attached to
an A-form RNA stem. A four-base bulge was inserted in
the stem, based on the bulge in ligand-free HIV-1 Tar
RNA [55]. The GNRA tetraloop and the four-base bulge
are on the same side of the pyr mRNA model because of
the intervening six base pairs.
PyrR contains no recognized RNA-binding structure or
sequence motifs, but a large basic region on the surface of
the PyrR dimer is the obvious choice for an RNA-binding
site (Figure 5). This surface is concave, whereas the
convex surface that includes the active-site cleft is nega-
tively charged. The model of pyr mRNA has a shape com-
plementary to the concave, basic, surface of PyrR, such
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Figure 5
Electrostatic surface potential of the PyrR dimer and a model for RNA
binding. The left-most and right-most images are opposite views of
PyrR along the dimer axis. The two active-site clefts are apparent in the
upper right and lower left corners of the right-most image, which
shows the acidic surface of PyrR and is in the same orientation as
Figure 3b. The basic surface is prominent in the left-most image. The
concavity of the basic surface is clear in the third image, which is a
side view of the dimer with the basic surface facing left. The model of
the 28-nucleotide pyr mRNA stem-loop shown in Figure 1b is docked
to the basic surface of PyrR in the two center images. The GNRA
tetraloop is at the top of the dimer and the four-base bulge fits into the
concavity in the basic surface. The displayed surface potential varies
approximately from –10 kT to 10 kT with acidic surfaces in red and
basic in blue. The electrostatic surface potential was calculated and
rendered in the program GRASP [72].
that the bulge created by the four unpaired nucleotides fits
into the concavity of PyrR (Figure 5). Nucleotides that are
protected from hydroxyl radical cleavage by PyrR (J D’Elia
and RLS, unpublished results) are on one side of the RNA
model, oriented towards the protein face. Among the eight
PyrR homologs, most of the conserved sidechains that are
on the surface of the dimer map to the proposed RNA-
binding surface. Prominent among these is the invariant
dimer loop (Figure 2), which forms the deepest part of the
concavity. The unique dimer contact found in PyrR may
therefore have evolved specifically to favor the binding of
RNA, at the expense of active-site interactions seen in
other type I PRTase dimers (Figure 4). The model repre-
sents an asymmetric RNA molecule bound to a symmetric
protein dimer; such behavior has been observed in the
complex of the RNA bacteriophage MS2 coat protein and a
19-nucleotide stem-loop RNA [56].
Mutagenesis results are consistent with the model of pyr
mRNA binding. A spontaneous mutant of PyrR, E23A,
was selected in a screen for defects in regulation by pyrim-
idines [35]; residue 23 maps to the concave surface of the
dimer. The sidechain of Glu23 in the wild-type protein
forms a salt bridge to the guanidinium groups of Arg19 and
Arg27, which contribute to the concave basic surface.
Glu23 may orient these arginine residues for RNA recog-
nition, or it may be directly involved in RNA binding.
Current site-directed mutagenesis studies are being
directed towards conserved basic residues on the proposed
RNA-binding surface of PyrR, particularly, Arg15, Arg19,
Arg27, Arg141, Arg146 and Lys152. Preliminary analysis of
R19Q and R146Q mutants reveals altered in vivo regula-
tion and in vitro RNA binding (H Savacool and RLS,
unpublished results).
Nucleotide binding to PyrR
Nucleoside monophosphates bind in the PRPP site of
type I PRTases in a variety of orientations [18,22,38,39];
however, in all of these complexes the 5¢ -phosphate group
is bound in the PRPP loop to residues at the N terminus
of the a helix (a 3 in PyrR), as SO42– is bound in PyrR crys-
tals. Base specificity is typically conferred through recog-
nition by residues of the hood subdomain. On the basis of
the complex between T. foetus HGXPRTase and GMP
[21], UMP was modeled into the active site of dimeric
PyrR (Figure 6). The protein structure accommodates
UMP without modification except for the sidechain of
Lys40, which forms a salt bridge to SO42– in the crystal
structures and was re-oriented to avoid close contacts with
the nucleotide.
Complete uracil specificity is provided by hydrogen bonds
with the backbone of Val162 in the hood subdomain,
namely, uracil N3 to the Val162 carbonyl and the Val162
NH to uracil O4. Similar hydrogen bonds to the protein
backbone are made by guanine in the complex of T. foetus
HGXPRTase and GMP, but the analogous amino acid is
further from the PRPP loop in HGXPRTase than in PyrR,
presumably to accommodate the larger purine base. Purine
bases would not fit in the PyrR site. Our model includes an
additional hydrogen bond to uracil O4 from the guani-
dinium group of invariant Arg138 in the dimer loop
(residues 138–144). The interaction of Arg138 with UMP
may transmit a structural change to the proposed RNA-
binding region of the protein. The flexible loop in type I
PRTases (residues 71–82) shields the active site from the
bulk solvent during catalysis. Conserved residues in this
loop are involved in PRPP binding [38]. The sidechain of
invariant Arg73 is less than 5 Å from uracil O2 of the UMP
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Figure 6
Stereo view of a model of UMP bound to the
active site of the PyrR monomer from the
dimer crystal structure. Protein residues
implicated in catalytic activity and/or UMP
coordination are shown with black bonds;
UMP is shown with white bonds; carbon
atoms are white; oxygen, nitrogen and
phosphorus are shaded. Potential hydrogen
bonds between the UMP base and protein are
shown as dashed lines. One of these
hydrogen bonds is to invariant Arg138 in the
dimer loop. The figure was prepared with the
program MOLSCRIPT [71].
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model; a small movement of the loop could position it
within hydrogen bonding distance of the uracil base.
The high concentration of SO42– in the crystallization
medium competes with UMP for binding to the PRPP
loop, and crystals of the PyrR–UMP complex cannot be
produced by soaking. Co-crystallization experiments
under a variety of high and low ionic strength conditions
and pH values, however, have also not yielded a crys-
talline complex. The affinity of PyrR for UMP in absence
of RNA is unknown. It may be that UMP binds nonspecif-
ically to the basic surface of PyrR in absence of RNA.
UTP also functions as a co-regulator of transcriptional
attenuation at approximately tenfold higher concentra-
tions than UMP, but UDP is not an effector [3]. It has
been interpreted from the results of these studies that
UTP binds PyrR differently than UMP or PRPP. Indeed,
nucleoside di- and triphosphates have not been observed
in the active sites of any type I PRTase structures and
have been shown to be excluded in one case [39]. PRPP
does not compete effectively with UTP in co-regulation of
transcription termination [3]. A different binding site for
UTP is not apparent in the PyrR structure.
PyrR functional mutants
Among the spontaneous mutants selected in a screen for
defects in regulation by pyrimidines are T41I, D106Y,
V134G and T156I [35]. Residue 106 is the second of the
invariant aspartate residues of the PRPP loop; tyrosine sub-
stitution would effectively block the UMP-binding site.
Thr41 is near the proposed binding site of the pyrophos-
phate group of PRPP and is conserved in most PyrR
homologs; substitution by the bulkier hydrophobic
isoleucine may curtail the flexibility of the PPi loop and
interfere with UMP and PRPP binding. Val134 is in the
hydrophobic core of PyrR. The V134G mutation may intro-
duce a destabilizing cavity in the protein interior or may
affect the transduction of the UMP-binding signal from the
active site to the RNA-binding site. There is a hydrogen
bond between the sidechains of invariant residues Thr156
and Arg138. Arg138 forms an important connection
between the UMP site and the basic RNA-binding surface.
The T156I mutation may therefore disrupt the orientation
of Arg138, and indirectly affect UMP binding or signaling
between the UMP and RNA sites.
Biological implications
Transcriptional attenuation proteins bind mRNA and
regulate transcription termination by inducing changes in
the secondary structure of the RNA. Expression of
genes for pyrimidine nucleotide biosynthesis in Bacillus
subtilis is regulated by the transcriptional attenuation
protein PyrR, together with the co-regulators UMP and
PRPP. PyrR binds three sites in the control regions of
pyr mRNA that have a consensus 28 to 30 nucleotide
stem-loop structure, allowing formation of downstream
terminator structures. PyrR is not related to other tran-
scriptional attenuation proteins, but is a homolog of the
type I phosphoribosyltransferases (PRTases) and proba-
bly exhibits very low levels of uracil PRTase catalytic
activity at physiological uracil concentrations. The three-
dimensional structure of PyrR reveals that its closest
structural homolog is Tritrichomonas foetus hypoxan-
thine-guanine-xanthine PRTase. A large basic region on
the otherwise acidic surface of the PyrR dimer is an
obvious choice for the RNA-binding site. Co-regulators
PRPP and UMP are proposed to bind to the enzyme
active site like the substrate and product molecules.
The primary, if not the only, physiological function of
PyrR is regulation of expression of the pyr operon. The
tertiary structure and surviving UPRTase activity of
PyrR demonstrate that this regulatory protein originated
from an ancestral PRTase in which UMP- and PRPP-
binding sites were retained and an RNA-binding surface
arose, apparently by a novel interaction between
monomeric units to form dimers in a fashion quite
unlike dimer formation by other PRTases. Another
instance in which a regulatory protein appears to have
arisen from a PRTase is the PurR repressor protein
from B. subtilis [47]. The ability of PurR to bind to pur
operator DNA is also regulated by PRPP and its
sequence is most similar to the B. subtilis XPRTase
sequence. We suggest that many proteins regulating
gene expression may have arisen from enzymes by evo-
lution of specific DNA- or RNA-binding surfaces.
Materials and methods
Crystallization and data collection
B. subtilis PyrR was overexpressed in the E. coli strain S˘ 408 using
plasmid pTSROX3 and purified as described previously [5]. The protein
was stored in 10 mM Tris-acetate, pH 7.5, at –80°C. Crystals of hexam-
eric PyrR were grown by hanging drop vapor diffusion at 20°C. Many con-
ditions favorable for crystal growth were obtained initially from the
Hampton Research Crystal Screen I [57], and some very small and thin
but extremely fragile crystals grew in 2.0 M ammonium sulfate. An addi-
tional search for more suitable conditions was conducted via an experi-
mentally designed orthogonal array screen [58], which yielded a
microcrystalline precipitate from PEG 6000 and ammonium sulfate. Final
conditions for crystal growth were obtained via refinement of these condi-
tions over a fine screen of 0.2 pH units. Protein at 10 mg/ml in 10 mM
Tris-acetate, pH 7.5, and 0.2% b -octylglucoside was mixed with an equal
volume of reservoir solution, and equilibrated against 13–16% PEG
6000, 300 mM ammonium sulfate, and 50 mM sodium succinate at
pH 5.1. Cube-shaped crystals appeared within 7–10 days and grew to
typical dimensions of 0.3 · 0.3 · 0.3 mm3 over a period of 6–8 weeks.
Crystals of dimeric PyrR were grown under the same conditions, except
for the addition of 2.0 mM Sm(NO3)3 to the reservoir solution; long thin
rods appeared overnight and grew to maximum dimensions of
0.05 · 0.15 · 1.0 mm3 over a period of 2–5 weeks. Other lanthanide ions
such as Ho3+, Lu3+ and Yb3+ could be used to obtain this crystal form, but
the crystals grown with Sm3+ were thicker and diffracted further. Crystals
were cryoprotected by soaking for approximately 30 seconds in 20%
(meso and DL)2,3-butanediol, 16% PEG 6000, 300 mM ammonium
sulfate, 50 mM sodium succinate pH 5.1 and 0.2% b -octylglucoside. The
crystals were quickly mounted in a small plastic fiber loop and either flash
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frozen in liquid ethane [59] and stored in liquid nitrogen for later use or
frozen in a nitrogen gas stream at 120K with an Oxford Cryostream.
X-ray diffraction data at two wavelengths near the LII absorption edge
of Sm (peak, l 1 = 1.6950 Å; inflection point, l 2 = 1.6959 Å) and at one
remote wavelength (l 3 = 0.9799 Å) were collected from a single
crystal of dimeric PyrR on Beamline 19 (BM14) of the European Syn-
chrotron Radiation Facility. Although anomalous scattering is greater at
the LIII absorption edge of Sm (1.846 A), greater absorption of X-rays
by the crystal, air and cryosolvent at this wavelength significantly dimin-
ish diffracted intensities. The data were recorded on a Mar Research
image plate detector. At each wavelength, 180° of data were recorded
as 2° oscillation images in the standard mode (i.e. inverse beam geom-
etry to minimize absorption effects was not used). A fresh spot on the
crystal was used to record data at each wavelength. Crystals of the
dimeric form of the 181-residue protein grew in the space group C2,
a = 76.7 Å, b = 57.7 Å, c = 55.0 Å, b = 129.0°, with one monomer in
the asymmetric unit.
X-ray diffraction data were collected from a single crystal of hexameric
PyrR frozen to 120K, using an R-axis II imaging plate system mounted
on a Rigaku RU-200 rotating anode (CuK a ) operated at 100 mA and
50 kV. Crystals of the hexameric form of the protein grew in the space
group R32, a = b = 100.58 Å, c = 275.15 Å (hexagonal setting), with
one dimer in the asymmetric unit.
All data were processed and scaled in the programs DENZO and
Scalepack [60]. Bijvoet pairs for the C2 crystal form data from l 1 and
l 2 were scaled independently and not merged. Negative intensities
were truncated and intensities were converted to structure factors and
placed on an approximate absolute scale in the program TRUNCATE
[61] from the CCP4 package [62]. Data collection and processing sta-
tistics for both crystal forms are shown in Table 1.
Structure determination and refinement
The structure of the dimeric form of PyrR was phased via the multiwave-
length anomalous diffraction (MAD) method from data collected at the
Sm LII edge on Sm3+ co-crystals. The diffraction data were treated as in
a conventional multiple isomorphous replacement experiment with the
inclusion of anomalous scattering. The three sets of data were placed
on the same relative scale in the program SCALEIT, and inspection of
an anomalous difference Patterson map calculated from data at l 1
revealed a high occupancy Sm3+ site on the crystallographic twofold
axis at x = 0, z = 0, and a lower occupancy Sm3+ site in a general posi-
tion. Difference Fourier syntheses confirmed that there were no addi-
tional Sm ions bound to the protein. For convenience, the y-coordinate
of the high occupancy Sm3+ was set to 0.0 during phase refinement,
which was performed in the program MLPHARE [63] using data with a
d = 20.0 to 2.3 Å. In this procedure, data from l 3 were used as the
‘native’ data set, and a unitary scattering factor was used for the Sm ion
(f¢ = f¢¢ = 1.00 electron) [64]. A total of 94% of all unique reflections
were assigned a phase in this procedure, and the final overall figure of
merit was 0.81. Phasing statistics are shown in Table 1. The resulting
electron-density map calculated from these MLPHARE phases was
clearly interpretable for the bulk of the protein (Figure 7). The program O
[65] was used to build an initial model for 165 residues of the protein,
with a resulting R factor of 45.6% for data with d = 6.0 to 2.7 Å. Simu-
lated annealing refinement of this model followed by cycles of positional
refinement against data with d = 6.0 to 2.3 Å in the program X-PLOR
[66] resulted in an Rwork of 28.0% and an Rfree of 40.5% (for a random
10% subset of all data). During all cycles of simulated annealing and
standard positional refinement, the y-coordinate of the high occupancy
Sm3+ ion was set to 0.0 to prevent the oscillation of this parameter in
the polar C2 space group. Subsequent refinement in X-PLOR employed
a bulk solvent mask and a Bayesian weighting scheme of structure
factors as implemented in the program HEAVY [67]. The occupancies
of the Sm3+ ion on the crystallographic twofold axis and Sm3+ ion in the
general position were fixed at 0.5 and 0.4, respectively, and their individ-
ual B factors were refined. Standard positional and individual isotropic
thermal factor refinement coupled with cycles of model rebuilding, data
extension and addition of solvent sites yielded a final Rwork of 19.2% and
Rfree of 23.3% for data with d = 15.0 to 1.6 Å. The current model
includes two Sm3+ ions, one sulfate ion, 263 waters, protein residues
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Table 1
Data collection and phasing statistics.
C2 crystal form R32 crystal form
l 1 (1.6950 Å) l 2 (1.6959 Å) l 3 (0.9799 Å) CuKa
Data range (Å) 40.0–2.20 40.0–2.25 40.0–1.55 40.0–2.3
No. of observations 33,325 37,191 104,445 92,317
No. of unique reflections 8342 8644 26,609 23,877
Completeness (%) 87.6 93.7 98.0 98.6
Rsym (%)* 4.2 5.4 8.5 5.0
Energy (keV) 7.315 7.311 12.653
f¢ (e–) –12.5 –16.2 –0.6
f¢¢ (e–) 16.9 13.7 5.9
Rcullis (iso)† 0.73 0.69
Rcullis (ano)‡ 0.41 0.50 0.75
Phasing power# 1.28 1.70
*Rsym =S |Io–<I>| / S Io, where Io are observed intensities and <I> are
average intensities for redundant measurements.
†Rcullis (iso) = S | | |FPH|obs +/–|FP|obs |–|FH|calc | / S | |FPH|obs +/–|FP|obs |,
where |FP|obs and |FPH|obs are the native and derivative observed
structure amplitudes, respectively, and |FH|calc is the calculated heavy
atom structure amplitude. ‡Rcullis (ano) = S | |DPH|obs–|DPH|calc | / S |DPH|obs ,
where |DPH|obs and |DPH|calc are the observed and calculated
anomalous differences for |FPH|. #Phasing power = rms ( |FH| / E ),
where E is the residual lack of closure error.
3–29, 34–73 and 82–180 (Asn180 is modeled as an alanine) and sev-
enteen residues modeled in two conformations. Due to the high degree
of conformational flexibility of the missing residues (30–33, 74–81), a
greater than usual number of solvent sites were modeled into the posi-
tive density peaks in these regions of the map. A last cycle of refinement
that included the 10% of the data used in the free R factor calculation
resulted in an R of 19.5%. Complete refinement statistics for the C2
crystal form can be found in Table 2.
One monomer of the dimeric form of PyrR was truncated prior to use as
a search model for the molecular replacement solution of the hexameric
form (residues 70–73, 82–85 of the flexible loop, the sidechain of
Lys40, and the sulfate ion were deleted). Rotation and translational
searches in the program AMORE [68] using data with d = 10.0 to 3.5 Å
located two protomers close enough to the crystallographic threefold
axis to generate a hexamer of D3 point symmetry. This solution resulted
in a correlation coefficient of 56.7% and an Rwork of 58.3%; rigid-body
refinement improved the correlation coefficient to 65.4% and Rwork to
38.1%. Subsequent rigid-body refinement in the program X-PLOR
against data with d = 10.0 to 3.0 Å resulted in an Rwork of 37.0% and
Rfree of 37.8% (for a random 10% subset of all data). Inspection of elec-
tron-density maps in the program O allowed a model for residues 30–33
of the previously disordered loop, the sidechain of Lys40 and a sulfate
ion in the PRPP loop to be built into both monomers. Simulated anneal-
ing refinement of this model followed by cycles of positional refinement
against data with d = 10.0 to 3.0 Å in X-PLOR resulted in an Rwork of
28.2% and an Rfree of 38.5%. Subsequent refinement in X-PLOR using
data with d = 15.0 to 2.3 Å employed non-crystallographic symmetry
restraints, a bulk solvent mask and a Bayesian weighting scheme of
structure factors as implemented in the program HEAVY. Standard posi-
tional and individual isotropic thermal factor refinement coupled with
model rebuilding and addition of solvent sites yielded a final Rwork of
19.2% and Rfree of 24.0% for the model, which includes two sulfate ions,
258 waters, residues 3–73, 84–180 (Leu86 is modeled as an alanine)
of the A monomer and residues 4–72, 83–180 of the B monomer. Six
residues of the A monomer and four residues of the B monomer were
modeled in two conformations. A last cycle of refinement that included
the 10% of the data used in the free R factor calculation resulted in an R
of 19.6%. Complete refinement statistics for the R32 crystal form can be
found in Table 2.
Accession numbers
The coordinates of the dimeric (1A3C) and hexameric (1A4X) PyrR
structures have been deposited with the Brookhaven Protein Data
Bank. Accession codes for the structure factors are R1A3CSF and
R1A4XSF, respectively. 
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